This Article Full Text Full Text (PDF) Submit a related Letter to the Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by De Luca, F. Articles by Baron, J. Search for Related Content PubMed PubMed Citation Articles by De Luca, F. Articles by Baron, J.

Sporadic Hypoparathyroidism Caused by de Novo Gain- of-Function Mutations of the Ca²⁺-Sensing Receptor¹

Developmental Endocrinology Branch, National Institute of Child Health and Human Development (F.D.L., E.E.M., K.K.W., J.B.), and Metabolic Diseases Branch, National Institute of Diabetes and Digestive and Kidney Disease (K.R., G.-F.F., A.M.S.), National Institutes of Health, Bethesda, Maryland 20892

Address all correspondence and requests for reprints to: Francesco De Luca, M.D., Building 10, Room 10N262, National Institutes of Health, 10 Center Drive, MSC 1862, Bethesda, Maryland 20892-1862. E-mail: delucaF{at}cc1.nichd.nih.gov

Activating mutations of the Ca²⁺-sensing receptor (CaR) gene have been identified in families with autosomal dominant hypoparathyroidism and in one patient with sporadic hypoparathyroidism. Here, we describe two additional patients with sporadic hypoparathyroidism. One patient presented with mild symptoms at age 18 yr; the other was severely symptomatic from infancy. A heterozygous missense mutation was identified in each patient. One mutation (L773R) involved the fifth transmembrane domain of the CaR, the other (N118K) affected the amino-terminal, extracellular domain. In both cases, the probands’ parents lacked the mutation, indicating that the mutations arose de novo. In expression studies the mutations shifted the concentration-response curve to the left and increased maximal activity. We conclude that 1) sporadic hypoparathyroidism can be caused by de novo gain-of-function mutations of the CaR; 2) the phenotype can vary from mild to life-threatening hypocalcemia; 3) gain-of-function mutations can involve not only extracellular regions, as previously reported, but also transmembrane domains of the CaR; and 4) the mechanism of activation can involve both increased receptor sensitivity to Ca²⁺ and increased maximal signal transduction.

This article has been cited by other articles:

				L Baumber, C Tufarelli, S Patel, P King, C A Johnson, E R Maher, and R C Trembath Identification of a novel mutation disrupting the DNA binding activity of GCM2 in autosomal recessive familial isolated hypoparathyroidism J. Med. Genet., May 1, 2005; 42(5): 443 - 448. [Full Text] [PDF]

				R. Goswami, T. Mohapatra, N. Gupta, R. Rani, N. Tomar, A. Dikshit, and R. K. Sharma Parathyroid Hormone Gene Polymorphism and Sporadic Idiopathic Hypoparathyroidism J. Clin. Endocrinol. Metab., October 1, 2004; 89(10): 4840 - 4845. [Abstract] [Full Text] [PDF]

				A. Ashraf and K. McCormick Index of Suspicion In the Nursery NeoReviews, August 1, 2004; 5(8): e356 - e359. [Full Text] [PDF]

				K. Sato, Y. Hasegawa, J. Nakae, K. Nanao, I. Takahashi, T. Tajima, N. Shinohara, and K. Fujieda Hydrochlorothiazide Effectively Reduces Urinary Calcium Excretion in Two Japanese Patients with Gain-of-Function Mutations of the Calcium-Sensing Receptor Gene J. Clin. Endocrinol. Metab., July 1, 2002; 87(7): 3068 - 3073. [Abstract] [Full Text] [PDF]

				T. Nagase, T. Murakami, T. Tsukada, R. Kitamura, N. Chikatsu, H. Takeo, N. Takata, H. Yasuda, S. Fukumoto, Y. Tanaka, et al. A Family of Autosomal Dominant Hypocalcemia with a Positive Correlation between Serum Calcium and Magnesium: Identification of a Novel Gain of Function Mutation (Ser820Phe) in the Calcium-Sensing Receptor J. Clin. Endocrinol. Metab., June 1, 2002; 87(6): 2681 - 2687. [Abstract] [Full Text] [PDF]

				A. Lienhardt, M. Bai, J.-P. Lagarde, M. Rigaud, Z. Zhang, Y. Jiang, M.-L. Kottler, E. M. Brown, and M. Garabedian Activating Mutations of the Calcium-Sensing Receptor: Management of Hypocalcemia J. Clin. Endocrinol. Metab., November 1, 2001; 86(11): 5313 - 5323. [Abstract] [Full Text] [PDF]

				M. Yamamoto, T. Akatsu, T. Nagase, and E. Ogata Comparison of Hypocalcemic Hypercalciuria between Patients with Idiopathic Hypoparathyroidism and Those with Gain-of-Function Mutations in the Calcium-Sensing Receptor: Is It Possible to Differentiate the Two Disorders? J. Clin. Endocrinol. Metab., December 1, 2000; 85(12): 4583 - 4591. [Abstract] [Full Text]

				O. M. Hauache, J. Hu, K. Ray, R. Xie, K. A. Jacobson, and A. M. Spiegel Effects of a Calcimimetic Compound and Naturally Activating Mutations on the Human Ca2+ Receptor and on Ca2+ Receptor/Metabotropic Glutamate Chimeric Receptors Endocrinology, November 1, 2000; 141(11): 4156 - 4163. [Abstract] [Full Text] [PDF]

				B. Kobilka Allosteric activation of the CaR by L-amino acids PNAS, April 25, 2000; 97(9): 4419 - 4420. [Full Text] [PDF]

				A. Lienhardt, M. Garabédian, M. Bai, C. Sinding, Z. Zhang, J.-P. Lagarde, J. Boulesteix, M. Rigaud, E. M. Brown, and M.-L. Kottler A Large Homozygous or Heterozygous In-Frame Deletion within the Calcium-Sensing Receptor's Carboxylterminal Cytoplasmic Tail That Causes Autosomal Dominant Hypocalcemia J. Clin. Endocrinol. Metab., April 1, 2000; 85(4): 1695 - 1702. [Abstract] [Full Text]

				J. L. Stock, R. S. Brown, J. Baron, J. A. Coderre, E. Mancilla, F. De Luca, K. Ray, and M. V. Mericq Autosomal Dominant Hypoparathyroidism Associated with Short Stature and Premature Osteoarthritis J. Clin. Endocrinol. Metab., September 1, 1999; 84(9): 3036 - 3040. [Abstract] [Full Text]

				R. Okazaki, N. Chikatsu, M. Nakatsu, Y. Takeuchi, M. Ajima, J. Miki, T. Fujita, M. Arai, Y. Totsuka, K. Tanaka, et al. A Novel Activating Mutation in Calcium-Sensing Receptor Gene Associated with a Family of Autosomal Dominant Hypocalcemia J. Clin. Endocrinol. Metab., January 1, 1999; 84(1): 363 - 366. [Abstract] [Full Text]

				K. K. Winer, J. A. Yanovski, B. Sarani, and G. B. Cutler Jr. A Randomized, Cross-Over Trial of Once-Daily Versus Twice-Daily Parathyroid Hormone 1-34 in Treatment of Hypoparathyroidism J. Clin. Endocrinol. Metab., October 1, 1998; 83(10): 3480 - 3486. [Abstract] [Full Text]

				M. Bai, S. Trivedi, and E. M. Brown Dimerization of the Extracellular Calcium-sensing Receptor (CaR) on the Cell Surface of CaR-transfected HEK293 Cells J. Biol. Chem., September 4, 1998; 273(36): 23605 - 23610. [Abstract] [Full Text] [PDF]

				T. Watanabe, M. Bai, C. R. Lane, S. Matsumoto, K. Minamitani, M. Minagawa, H. Niimi, E. M. Brown, and T. Yasuda Familial Hypoparathyroidism: Identification of a Novel Gain of Function Mutation in Transmembrane Domain 5 of the Calcium-Sensing Receptor J. Clin. Endocrinol. Metab., July 1, 1998; 83(7): 2497 - 2502. [Abstract] [Full Text]

				A. A. Jensen, T. A. Spalding, E. S. Burstein, P. O. Sheppard, P. J. O'Hara, M. R. Brann, P. Krogsgaard-Larsen, and H. Brauner-Osborne Functional Importance of the Ala116-Pro136 Region in the Calcium-sensing Receptor. CONSTITUTIVE ACTIVITY AND INVERSE AGONISM IN A FAMILY C G-PROTEIN-COUPLED RECEPTOR J. Biol. Chem., September 15, 2000; 275(38): 29547 - 29555. [Abstract] [Full Text] [PDF]

				M. Hungs, J. Fan, L. Lin, X. Lin, R. A. Maki, and E. Mignot Identification and Functional Analysis of Mutations in the Hypocretin (Orexin) Genes of Narcoleptic Canines Genome Res., April 1, 2001; 11(4): 531 - 539. [Abstract] [Full Text]